Phage PM16 Therapy Induce Long-Term Protective Immunity Against Proteus mirabilis via Macrophage Priming
Pathogens · 2026
DOI: 10.3390/pathogens15010099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Lina Al Allaf und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, Novosib…. Hauptthemen laut MEDLINE: Proteus mirabilis, Macrophages, Proteus Infections, Phage Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Ministry of Education and Science of Russia, Russian Scientific Foundation.
Abstract (Originalsprache)
Bacteriophages, traditionally viewed solely as antibacterial agents, are increasingly being studied for their immunomodulatory properties. In this study, we demonstrate that PM16 phage therapy not only effectively controls subcutaneous Proteus mirabilis infection in mice but also induces long-term specific humoral immunity against subsequent reinfection. This immunomodulatory effect was dose-dependent. In vitro, PM16 directly activates macrophages, leading to increased production of proinflammatory cytokines (tumor necrosis factor-α and interleukin-1β) and inducible nitric oxide synthase, and enhances macrophage bactericidal activity against P. mirabilis. We assume that the enhancement of the adaptive immune response is mediated not by the phage acting as a classical antigenic adjuvant but by its ability to prime innate immune cells, specifically macrophages. This priming leads to more efficient bacterial clearance, antigen presentation, and the formation of protective immunological memory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia.
ORCID-Profile: Lina Al Allaf, Anton V Chechushkov, Vera V Morozova, Yulia N Kozlova, Nina V Tikunova
Förderung
- Russian Science Foundation
- Ministry of Education and Science of Russia
- Russian Scientific Foundation
- Ministry of Education and Science
Zitieren
APA
Al Allaf, L., Chechushkov, A. V., Morozova, V. V., Kozlova, Y. N., Ushakova, T. A., & Tikunova, N. V. (2026). Phage PM16 Therapy Induce Long-Term Protective Immunity Against Proteus mirabilis via Macrophage Priming. Pathogens. https://doi.org/10.3390/pathogens15010099
Vancouver
Al Allaf L, Chechushkov AV, Morozova VV, Kozlova YN, Ushakova TA, Tikunova NV. Phage PM16 Therapy Induce Long-Term Protective Immunity Against Proteus mirabilis via Macrophage Priming. Pathogens. 2026. doi:10.3390/pathogens15010099
BibTeX
@article{AlAllaf2026,
author = {Al Allaf, Lina and Chechushkov, Anton V and Morozova, Vera V and Kozlova, Yulia N and Ushakova, Tatiana A and Tikunova, Nina V},
title = {Phage PM16 Therapy Induce Long-Term Protective Immunity Against Proteus mirabilis via Macrophage Priming},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15010099}
}
EUVIMED